Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Mar;108(3):264-267.
doi: 10.1111/ejh.13729. Epub 2021 Dec 13.

mRNA COVID-19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta-analysis

Stefano Molica  1 , Diana Giannarelli  2 , Emili Montserrat  3
Affiliations
Meta-Analysis

mRNA COVID-19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta-analysis

Stefano Molica et al. Eur J Haematol. 2022 Mar.
No abstract available

Keywords: chronic lymphocytic leukemia; mRNA SARS-CoV-2 vaccine; meta-analysis; systematic review; treatment status.

PubMed Disclaimer

References

REFERENCES

    1. Molica S, Giannarelli D, Lentini M et al. A clue to better select chronic lymphocytic leukemia patients with optimal response to BNT162b2 mRNA COVID-19 vaccine. Paper presented at 63rd ASH Annual Meeting and Exposition; December 11-14, 2021; Atlanta, GA, Abstract 3740.
    1. Creech CB, Walker SC, Samuels RJ. SARS-CoV-2 vaccines. JAMA. 2021;325(13):1318-1320.
    1. Griffiths EA, Segal BH. Immune responses to COVID-19 vaccines in patients with cancer: promising results and a note of caution. Cancer Cell. 2021;39:1045-1047.
    1. Herishanu Y, Avivi I, Aharon A, et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia. Blood. 2021;137(23):3165-3173.
    1. Forconi F, Moss P. Perturbation of the normal immune system in patients with CLL. Blood. 126(5):573-581.

MeSH terms

LinkOut - more resources